Integrative metagenomics and metabolomics reveal age-associated gut microbiota and metabolite alterations in a hamster model of COVID-19Original paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study explored how aging shapes gut microbiota and metabolite changes during COVID-19. Researchers used shotgun metagenomics and targeted metabolomics in a hamster model of SARS-CoV-2 infection. They compared young and aged animals at the disease peak and during recovery. By integrating microbiome, plasma metabolite, and clinical data, the team sought bacterial and metabolic signatures linked to severe and long-term disease outcomes.
Who was studied?
The model was Syrian golden hamsters, a preclinical model of COVID-19. Two age groups were compared: young at 2 months and aged at 22 months, roughly equivalent to 80 human years. Hamsters were infected intranasally with an ancestral SARS-CoV-2 strain. Animals were sampled at day 3, day 7 (acute phase), and day 22 (resolution), with 3 to 6 hamsters per group. Cecal contents, plasma, and lungs were analyzed.
What were the most important findings?
Aged hamsters had significantly higher lung viral loads at day 3 and day 7, continued losing weight past day 8, and never regained baseline weight. They showed more lung fibrosis by day 22. Infection reshaped the aged gut microbiome most, raising Bacteroidota from 27 to 47 percent and Pseudomonadota from 0.05 to 3 percent, while beneficial Lachnospiraceae fell. Aged animals had persistent drops in tryptophan, phenylalanine, glutamic acid, and indoleacetic acid, which correlated with poor weight recovery and fibrosis. Young hamsters showed protective links for carnosine and cis-aconitic acid.
What are the greatest implications of this study?
The findings support age-specific, microbiome-targeting strategies for viral pneumonia. Aging alters gut composition and function in ways that track with worse and longer-lasting disease. Specific amino acids and indoleacetic acid emerged as candidate markers of recovery in aged animals. This is a small hamster study, and correlation does not prove causation, so fecal transfer and human validation are needed. Results argue for nutritional and amino acid support in elderly patients.